Javascript must be enabled to continue!
Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia
View through CrossRef
The first recognized cases of equine granulocytic ehrlichiosis in New England are described. The DNA sequence of the 16S rRNA gene of the causative ehrlichia was found to be identical to that of the human granulocytotropic ehrlichia, the agent of human granulocytic ehrlichiosis.
American Society for Microbiology
Title: Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia
Description:
The first recognized cases of equine granulocytic ehrlichiosis in New England are described.
The DNA sequence of the 16S rRNA gene of the causative ehrlichia was found to be identical to that of the human granulocytotropic ehrlichia, the agent of human granulocytic ehrlichiosis.
Related Results
Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent)
Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent)
A Thoroughbred filly that developed clinical signs of equine granulocytic ehrlichiosis following inoculation with the human granulocytotropic ehrlichia was shown to be resistant to...
Experimental cross‐infections with
Ehrlichia phagocytophila
and human granulocytic ehrlichia‐like agent in cows and horses
Experimental cross‐infections with
Ehrlichia phagocytophila
and human granulocytic ehrlichia‐like agent in cows and horses
Four cows and four horses were infected experimentally with
Ehrlichia phagocytophila
, the cause of tickborne fever in ruminants, and with h...
Rocky Mountain spotted fever in dogs and its differentiation from canine ehrlichiosis
Rocky Mountain spotted fever in dogs and its differentiation from canine ehrlichiosis
SUMMARY
Rocky Mountain spotted fever (rmsf) or ehrlichiosis was diagnosed in dogs on the basis of specific immunofluorescent testing for each disease. Comparisons between clinical ...
Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction
Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction
Polymerase chain reaction (PCR) primers derived from a variable region of the 16S rRNA gene sequence were used to amplify DNA specifically from Ehrlichia chaffeensis (the recently ...
Transmission ofAnaplasma phagocytophila(Human Granulocytic Ehrlichiosis Agent) in Horses Using Experimentally Infected Ticks (Ixodes scapularis)
Transmission ofAnaplasma phagocytophila(Human Granulocytic Ehrlichiosis Agent) in Horses Using Experimentally Infected Ticks (Ixodes scapularis)
SummaryMost human granulocytic ehrlichiosis (HGE) studies carried out in horses use needle inoculation of infected leucocytes or cell cultures. This route of inoculation does not a...
Seroprevalence of
Ehrlichia canis
and of Canine Granulocytic Ehrlichia Infection in Dogs in Switzerland
Seroprevalence of
Ehrlichia canis
and of Canine Granulocytic Ehrlichia Infection in Dogs in Switzerland
ABSTRACT
Serum samples from 996 dogs in Switzerland were examined for antibodies to
Ehrlichia canis
and to the agent causing canine g...
Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims
Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims
To date, vaccination is one of the most efficient methods of prevention against equine infectious diseases. The vaccinology session, which was organised during the annual meeting o...
Molecular prevalence of emerging Anaplasma and Ehrlichia pathogens in apparently healthy dairy cattle in peri-urban Nairobi, Kenya
Molecular prevalence of emerging Anaplasma and Ehrlichia pathogens in apparently healthy dairy cattle in peri-urban Nairobi, Kenya
Abstract
Background
Anaplasma and Ehrlichia species are tick-borne pathogens of both veterinary and public health importance. The current status of these pathogens, including emerg...

